title: Racial disparities in the use of second-generation antipsychotics for the treatment of schizophrenia.
abstract: OBJECTIVE
  Despite recommendations that second-generation antipsychotics be used as first-line treatment for schizophrenia, previous studies have shown that blacks are less likely than whites to receive these newer drugs. This study determined the rate at which second-generation antipsychotics were prescribed to whites and blacks with schizophrenia who were treated as outpatients.
  
  
  METHODS
  Data were collected from a community mental health clinic affiliated with an academic center in Rochester, New York. Multivariate logistic regression was used to examine the association between race and the receipt of a second-generation antipsychotic.
  
  
  RESULTS
  Data were available for 456 patients: 276 whites and 180 blacks. Ninety-five percent received a second-generation antipsychotic. Whites were approximately six times more likely than blacks to receive a second-generation medication, after the analysis controlled for clinical and sociodemographic factors (p<.001). Most of this difference appeared to be driven by a disparity in the use of clozapine.
  
  
  CONCLUSIONS
  In this sample, blacks were less likely than whites to receive second-generation antipsychotics, demonstrating a persistent gap in the quality of care for patients with schizophrenia.
authors.affiliation: Department of Community and Preventive Medicine, University of Rochester, New York, USA. juliem@jhu.edu
authors.forename: Julie B
authors.initials: JB
authors.lastname: Mallinger
authors.forename: Susan G
authors.initials: SG
authors.lastname: Fisher
authors.forename: Theodore
authors.initials: T
authors.lastname: Brown
authors.forename: J Steven
authors.initials: JS
authors.lastname: Lamberti
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D003024:Clozapine / Q000627:therapeutic use*; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D004363:Drug Utilization / Q000706:statistics & numerical data*; D005006:Ethnicity / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy*; D014481:United States / Q000453:epidemiology
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine